In the wake of a far right Texas judge’s dangerous ruling that could lead to a key abortion drug being removed from pharmacies across the country, nearly every Democrat in Congress has signed on to a legal filing seeking to block the ruling and protect abortion access.
The brief supporting the Biden administration’s appeal of the ruling filed this week was signed by 240 Democrats, in an effort led by lawmakers like Senate Majority Leader Chuck Schumer (D-New York), Sen. Bernie Sanders (I-Vermont) and House Minority Leader Hakeem Jeffries (D-New York).
The lawmakers are seeking a stay on District Court Judge Matthew Kacsmaryk’s ruling on Friday that would suspend the Food and Drug Administration’s (FDA) 23-year-old approval of mifepristone, a drug taken in abortion procedures and used to manage certain hormonal disorders.
In the brief, the lawmakers say that Kacsmaryk has launched an unprecedented attack on not just mifepristone, but also the way that the FDA approves any and all drugs, as many legal analysts have also noted in recent days.
“By staying FDA’s two-decade old approval of mifepristone, the district court has disrupted the longstanding statutory framework and erroneously awarded an extraordinary remedy. Decades after FDA’s initial approval … the district court intruded into FDA’s drug approval process, casting a shadow of uncertainty over its decisions,” the lawmakers argued in the brief.
“The perils of this unwarranted judicial intervention into science-based determinations can hardly be overstated,” the brief says, warning that the “perilous consequences” of Kacsmaryk’s ruling “reach far beyond mifepristone.” The lawmakers also warn that suspending access to mifepristone would worsen an already widespread crisis of abortion access that is also affecting other crucial reproductive services like care for miscarriages, also known as spontaneous abortions.
“Rather than affording any deference to FDA, the district court appears to have second-guessed FDA’s expert determinations with cherry-picked anecdotes and studies, and on that basis, imposed a remedy that could significantly upend the status quo,” they wrote.
The brief was signed by every member of the Democratic caucus in the Senate except for conservative Sen. Joe Manchin (D-West Virginia), who is a vocal opponent of abortion rights. It was also signed by 190 out of 213 Democrats in the House, including progressive members like Rep. Alexandria Ocasio-Cortez (D-New York) and Congressional Progressive Caucus Chair Rep. Pramila Jayapal (D-Washington), and excluding conservative Democrats like Rep. Henry Cuellar (D-Texas).
The brief was filed in support of an appeal by the Department of Justice on Monday to a federal appeals court to ensure that mifepristone stays on the market until the case can be settled, as it is likely to reach the Supreme Court. Currently, the drug is still available in states where it is legal, after a federal judge in Washington filed a competing order to Kacsmaryk’s on Friday, mandating that authorities keep the drug in the market.
We’re not backing down in the face of Trump’s threats.
As Donald Trump is inaugurated a second time, independent media organizations are faced with urgent mandates: Tell the truth more loudly than ever before. Do that work even as our standard modes of distribution (such as social media platforms) are being manipulated and curtailed by forces of fascist repression and ruthless capitalism. Do that work even as journalism and journalists face targeted attacks, including from the government itself. And do that work in community, never forgetting that we’re not shouting into a faceless void – we’re reaching out to real people amid a life-threatening political climate.
Our task is formidable, and it requires us to ground ourselves in our principles, remind ourselves of our utility, dig in and commit.
As a dizzying number of corporate news organizations – either through need or greed – rush to implement new ways to further monetize their content, and others acquiesce to Trump’s wishes, now is a time for movement media-makers to double down on community-first models.
At Truthout, we are reaffirming our commitments on this front: We won’t run ads or have a paywall because we believe that everyone should have access to information, and that access should exist without barriers and free of distractions from craven corporate interests. We recognize the implications for democracy when information-seekers click a link only to find the article trapped behind a paywall or buried on a page with dozens of invasive ads. The laws of capitalism dictate an unending increase in monetization, and much of the media simply follows those laws. Truthout and many of our peers are dedicating ourselves to following other paths – a commitment which feels vital in a moment when corporations are evermore overtly embedded in government.
Over 80 percent of Truthout‘s funding comes from small individual donations from our community of readers, and the remaining 20 percent comes from a handful of social justice-oriented foundations. Over a third of our total budget is supported by recurring monthly donors, many of whom give because they want to help us keep Truthout barrier-free for everyone.
You can help by giving today during our fundraiser. We have 5 days to add 340 new monthly donors. Whether you can make a small monthly donation or a larger gift, Truthout only works with your support.